AUGENIMPLANTAT MIT AXITINIB-POLYMORPH IV
European patent · EP4583930 · In force
Register entry
- Publication number
- EP4583930
- Application number
- EP24725981
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Apr 9, 2024
- Published
- Jul 16, 2025
- Granted
- Sep 2, 2026
- Protection ends at the latest
- Apr 8, 2044
- Next annual fee due
- Apr 30, 2027
- IPC classes
- A61L 27/18 (2006.01)A61K 9/00 (2006.01)A61L 27/52 (2006.01)A61L 27/54 (2006.01)
- Priority
- US 202363458558 P 11.04.2023US 202363546064 P 27.10.2023US 202363609334 P 12.12.2023
- PCT application
- PCT/US2024/023688 09.04.2024
- PCT publication
- WO2024/215649 17.10.2024
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 2, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 02.09.2026
Parties
Inventor
BLIZZARD, Charles D.
Bedford, MA 01730, US
KAHN, Erica
Bedford, MA 01730, US
JARRETT, Peter
Bedford, MA 01730, US
GURSES-OZDEN, Rabia
Bedford, MA 01730, US
EL-HAYEK, Rami
Bedford, MA 01730, US
BRAUN, Elizabeth
Bedford, MA 01730, US
IACONA, Joseph
Bedford, MA 01730, US
PATEL, Chintan
Bedford, MA 01730, US
RANSBOTTOM, Mark
Bedford, MA 01730, US
SHERMAN, Olivia
Bedford, MA 01730, US
ISOM, William
Bedford, MA 01730, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.